Q1 2019 13F Holders as of 31 Mar 2019
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
19,749,035
-
Share change
-
+3,349,108
-
Total reported value
-
$158,958,458
-
Price per share
-
$8.05
-
Number of holders
-
69
-
Value change
-
+$26,962,745
-
Number of buys
-
40
-
Number of sells
-
18
Institutional Holders of AEGLEA BIOTHERAPEUTICS INC - COM (AGLE) as of Q1 2019
As of 31 Mar 2019,
AEGLEA BIOTHERAPEUTICS INC - COM (AGLE) was held by
69 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
19,749,035 shares.
The largest 10 holders included
Nantahala Capital Management, LLC, ORBIMED ADVISORS LLC, BAKER BROS. ADVISORS LP, BlackRock Inc., ADAGE CAPITAL PARTNERS GP, L.L.C., Aisling Capital Management LP, VANGUARD GROUP INC, SPHERA FUNDS MANAGEMENT LTD., Rock Springs Capital Management LP, and JENNISON ASSOCIATES LLC.
This page lists
69
institutional shareholders reporting positions in this security
for the Q1 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.